[精神药物相关体重增加——肠促胰岛素/双效肠促胰岛素是一种选择吗？] - Suppr

[Psychotropic drug-related weight gain-Are incretins/twincretins an option?].

作者信息

Paulzen Michael

机构信息

Alexianer Aachen GmbH, Alexianer Zentrum für seelische Gesundheit Aachen | Gangelt, Alexianergraben 33, 52062, Aachen, Deutschland.

出版信息

Nervenarzt. 2025 Jan;96(1):93-96. doi: 10.1007/s00115-024-01788-1. Epub 2025 Jan 8.

DOI:10.1007/s00115-024-01788-1

PMID:39774952

Abstract

摘要

相似文献

[Psychotropic drug-related weight gain-Are incretins/twincretins an option?].

Nervenarzt. 2025 Jan;96(1):93-96. doi: 10.1007/s00115-024-01788-1. Epub 2025 Jan 8.

The emerging role of incretins and twincretins.

Nat Rev Endocrinol. 2022 Feb;18(2):73-74. doi: 10.1038/s41574-021-00607-w.

Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'.

Diabetes Obes Metab. 2016 Sep;18(9):847-54. doi: 10.1111/dom.12685. Epub 2016 Jun 7.

Psychotropic drug-induced genetic-epigenetic modulation of CRTC1 gene is associated with early weight gain in a prospective study of psychiatric patients.

Clin Epigenetics. 2019 Dec 26;11(1):198. doi: 10.1186/s13148-019-0792-0.

Weight gain associated with taking psychotropic medication: an integrative review.

Int J Ment Health Nurs. 2011 Jun;20(3):202-22. doi: 10.1111/j.1447-0349.2010.00721.x. Epub 2011 Feb 18.

Weight Gain and Mental Health in the Canadian Prison Population.

J Correct Health Care. 2021 Mar;27(1):51-57. doi: 10.1089/jchc.19.04.0039.

Psychotropic drugs, eating behaviour and weight gain.

Curr Opin Psychiatry. 2024 Sep 1;37(5):331-336. doi: 10.1097/YCO.0000000000000953. Epub 2024 Jun 10.

Induction of obesity by psychotropic drugs.

Ann N Y Acad Sci. 1987;499:203-15. doi: 10.1111/j.1749-6632.1987.tb36212.x.

The effect of a novel dietary intervention on weight loss in psychotropic drug-induced obesity.

Psychopharmacol Bull. 2002 Summer;36(3):55-9.

[Update twincretins: first clinical experience and important facts].

MMW Fortschr Med. 2024 Dec;166(21-22):67-69. doi: 10.1007/s15006-024-4428-8.

本文引用的文献

Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality.

JAMA Netw Open. 2024 Aug 1;7(8):e2423385. doi: 10.1001/jamanetworkopen.2024.23385.

Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial.

Lancet Diabetes Endocrinol. 2024 Mar;12(3):162-173. doi: 10.1016/S2213-8587(23)00356-X. Epub 2024 Feb 5.

Psychotropic Drug-Related Weight Gain and Its Treatment.

Am J Psychiatry. 2024 Jan 1;181(1):26-38. doi: 10.1176/appi.ajp.20230922.

Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series.

Ther Adv Psychopharmacol. 2023 Apr 19;13:20451253231165169. doi: 10.1177/20451253231165169. eCollection 2023.

Reduction in Multiple Cardiometabolic Risk Factors With Combined Olanzapine/Samidorphan Compared With Olanzapine: Post Hoc Analyses From a 24-Week Phase 3 Study.

Schizophr Bull. 2023 Mar 15;49(2):454-463. doi: 10.1093/schbul/sbac144.

Tirzepatide Once Weekly for the Treatment of Obesity.

N Engl J Med. 2022 Jul 21;387(3):205-216. doi: 10.1056/NEJMoa2206038. Epub 2022 Jun 4.

Metformin in the management of antipsychotic-induced weight gain in adults with psychosis: development of the first evidence-based guideline using GRADE methodology.

Evid Based Ment Health. 2022 Feb;25(1):15-22. doi: 10.1136/ebmental-2021-300291. Epub 2021 Sep 29.

Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study.

Schizophr Bull. 2022 Jan 21;48(1):166-175. doi: 10.1093/schbul/sbab087.

Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis.

Syst Rev. 2020 Jan 16;9(1):17. doi: 10.1186/s13643-020-1274-3.

Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial.

JAMA Psychiatry. 2017 Jul 1;74(7):719-728. doi: 10.1001/jamapsychiatry.2017.1220.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Psychotropic drug-related weight gain-Are incretins/twincretins an option?].

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献